Glycosaminoglycan

Biomarker2 papers1 finding

Animals1
Cells1

Interventions

1

Allogeneic FE002-CART chondroprogenitor spheroids

upin human cells1Very low certainty

1 study

Allogeneic FE002-CART chondroprogenitor spheroids increase glycosaminoglycan in human cells (10-fold).
Cellscompared to traditional matrix-seeded (MACI) platforms
Engineering Allogeneic FE002-Cart Chondroprogenitor Spheroids for Large Knee Chondral Defects: Investigating Microenvironmental Cues for Functional Control, GMP Formulation, and Logistical Viability · Pharmaceutics · 20 Aug 2026

Allogeneic FE002-CART chondroprogenitor spheroids →

Latest

7

Angiologiia I Sosudistaia KhirurgiiaHuman trial13 Sep

[Effect of sulodexide on the walking, erectile and cognitive functions based on the findings of the ANDANTE study]

ACS Biomaterials Science & EngineeringAnimals8 Sep

Synergistic Tuning of Pore Architecture and Mechanical Properties in a Biomimetic COL-HA-PVA Hydrogel Directs BMSC Chondrogenesis for Osteochondral Regeneration

PharmaceuticsCells27 Aug

Engineering Allogeneic FE002-Cart Chondroprogenitor Spheroids for Large Knee Chondral Defects: Investigating Microenvironmental Cues for Functional Control, GMP Formulation, and Logistical Viability

Journal of BiomechanicsCells22 Aug

Aged tendons have impaired mechanosensitivity and lower thresholds for injury under dynamic compression

AAIC 2025 AbstractHumans24 Dec

Plasma proteomics reveals novel protein signatures associated with dementia in chronic pain individuals: a prospective cohort study

AAIC 2025 AbstractHumans23 Dec

Plasma proteomics reveals novel protein signatures associated with dementia in chronic pain individuals: a prospective cohort study

AHA Scientific Sessions 2025 AbstractHuman trial3 Nov

Direct Vascular Endothelial Assessment Highlights the Pleotropic Anti-Inflammatory Properties of Statin Therapy: Findings from the American Heart Association Cardiometabolic Health Strategically Focused Research Network